Circulating Endothelial Microparticles and Correlation of Serum 1,25-Dihydroxyvitamin D with Adiponectin, Nonesterified Fatty Acids, and Glycerol from Middle-Aged Men in China

Wan, Zhongxiao; Yu, Lugang; Cheng, Jinbo; Zhang, Zengli; Xu, Baohui; Pang, Xing; Zhou, Hui; Lei, Ting

doi:https://doi.org/10.1155/2016/8420768

BioMed Research International

On this page

Abstract Introduction Materials and Methods Results Discussion Limitations Conclusions Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2016 | Article ID 8420768 | https://doi.org/10.1155/2016/8420768

Circulating Endothelial Microparticles and Correlation of Serum 1,25-Dihydroxyvitamin D with Adiponectin, Nonesterified Fatty Acids, and Glycerol from Middle-Aged Men in China

Zhongxiao Wan,^1,2Lugang Yu,³Jinbo Cheng,¹Zengli Zhang,⁴Baohui Xu,³Xing Pang,^1,3Hui Zhou,³and Ting Lei³

Academic Editor: Yoshifumi Saisho

Received08 Mar 2016

Revised29 Apr 2016

Accepted09 May 2016

Published25 May 2016

Abstract

The aim of the present study is (1) to determine the correlation between circulating 1,25-dihydroxyvitamin D [25(OH)D] and adiponectin, nonesterified fatty acids (NEFAs), and glycerol and (2) to determine the alterations in circulating endothelial microparticles (EMPs) in Chinese male subjects with increased body mass index (BMI). A total of 45 male adults were enrolled with varied BMI [i.e., lean, overweight (OW), and obese (OB), per group]. Blood samples were collected under overnight fasting condition, and plasma was isolated for the measurement of endothelial microparticles (EMPs), total and high-molecular weight (HMW) adiponectin, 25(OH)D, nonesterified fatty acids (NEFAs), and glycerol. Circulating 25(OH)D levels were inversely associated with total adiponectin, NEFA, and glycerol levels. There is no difference for CD62E+ or CD31+/CD42b− EMPs among 3 groups. In Chinese male adults with varied BMI, an inverse correlation existed between 25(OH)D levels and total adiponectin, NEFA, and glycerol levels; and there is no significant difference for CD62E+ or CD31+/CD42b− EMPs among lean, overweight, and obese subjects.

1. Introduction

Obesity is one of the main causal factors for enhancing the morbidity and mortality rates of metabolic chronic diseases such as type 2 diabetes (T2DM) and cardiovascular diseases (CVDs) worldwide [1]. The considerable role of adipose tissue in these complications is well recognized. This is largely owing to the fact that adipose tissue secretes a wide range of biologically active adipokines and cytokines with modulatory effects on glucose homeostasis and lipid metabolism [2]. Among these, adiponectin is one of the most abundant adipokines secreted from adipose tissue [3] and circulating adiponectin is inversely related to adiposity [4]. Circulating adiponectin is composed of trimer, hexamer, and high-molecular weight (HMW) forms [5]. HMW form is considered as the major active form of adiponectin and a better marker for insulin resistance and metabolic syndrome [6]. Another main function of adipose tissue is providing fuel for the body under energy demanding condition via lipolysis, which will result in elevation in circulating glycerol and FFAs level [7, 8]. Vitamin D deficiency is also prevalent in obese subjects [9] and serum 1,25-dihydroxyvitamin D [25(OH)D] is inversely associated with BMI [10]. Existing evidence also suggested an association between circulating 25(OH)D and adiponectin levels. For example, via the Mendelian randomization approach, Husemoen et al. [11] speculated that a possible causal association existed between serum 25(OH)D and total adiponectin, while further studies are required to confirm this. Consequently, more studies are required to explore the associations between vitamin D and adiponectin (total and HMW form), NEFAs, and glycerol.

Endothelial microparticles (EMPs) are complex vesicular structures shed from endothelial cells in response to stimuli such as inflammatory activation and/or apoptosis [12]. They are now considered as novel biomarkers of endothelial activation and damage that are increased in overweight/obese individuals at risk for metabolic syndrome (MetS) [13, 14]. It remains unknown whether EMPs will be altered in the transition from lean to obese status from Chinese subjects.

With the above points in mind, we thought it is important (1) to determine the correlation between vitamin D and adiponectin, NEFAs, and glycerol and (2) to determine the alterations in circulating EMPs in Chinese male subjects with increased BMI. This will help us understand the complex biology of obesity in adipose tissue and its roles in affecting circulating markers (such as vitamin D and EMPs). We hypothesized that (1) positive correlations existed between vitamin D and adiponectin (total and HMW form), while negative correlations existed between vitamin D and NEFAs and glycerol, and that (2) EMPs might be altered under obese condition.

2. Materials and Methods

2.1. Study Subjects

From October to December 2014, we enrolled 45 male adults (aged 45–60 years) with no history of cardiovascular disease or type 2 diabetes from Suzhou Industrial Park area, Suzhou, China. Among these, there are 15 subjects in lean (LN), overweight (OW), and obese (OB) group, respectively. According to the working group on obesity in China (WGOC) [15], lean was defined as kg/m²; OW was defined as kg/m²; and OB was defined as kg/m². All subjects recruited did not have metabolic syndrome or hypertension, while subjects in the obese group have dyslipidemia characterized by elevated triglyceride. The present study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving human subjects were approved by the Human Research and Ethical Committee of the Soochow University and all participants provided signed informed consent.

2.2. Biological Sampling and Measurement

Subjects reported to the laboratory after an overnight fast at 8 am. Blood samples (5 mL) were obtained by venipuncture from an antecubital vein and collected into EDTA tubes. Blood was centrifuged at 1500 g for 10 mins at 4°C and plasma immediately frozen at −80°C for subsequent analyses. Plasma 25(OH)D was analyzed using 25 OH vitamin D reagent based on the chemiluminescent immunoassay (CLIA). Total and HMW adiponectin were measured via ELISA kit from ALPCO Immunoassays (cat#47-ADPMS-E01). Plasma glycerol and NEFAs were measured by glycerol assay kit (cat#E1002, Applygen Technologies, Beijing, China) and Labassay NEFA kit (cat#294-63601, Wako, Osaka, Japan), respectively. The assays for adiponectin, HMW adiponectin, glycerol, and NEFAs were run in duplicate; the average CV for duplicates is <10% in our laboratory.

2.3. Endothelial Microparticles (EMPs) Measurement

Circulating EMPs were measured in platelet poor plasma by flow cytometry following the methods of Jenkins et al. [16]. In brief, frozen plasma samples were thawed at room temperature for 20 minutes and centrifuged at 1500 g for 15 minutes. The top two-thirds of plasma were then further centrifuged at 1500 g for another 15 minutes to obtain platelet poor plasma. The top 100 μL of platelet poor plasma was then incubated with fluorochrome labeled antibodies specific for PE-CD42b, FITC-CD31, and APC-CD62E for 20 minutes in the dark at 4°C. Samples were then fixed with 93 μL of 2% paraformaldehyde and diluted up to 500 μL with sterile, 0.2 μM filtered, PBS and analyzed on a FC500 Beckman Coulter (CA, USA). A microparticle size gate was determined using 900 nm Latex beads which is carboxylate-modified polystyrene. Unstained and fluorescence minus one controls were used to differentiate between true events and background/debris. EMPs were identified as CD62E+ and CD31+/CD42b− events within the microparticle size gate.

2.4. Statistical Analysis

All data are presented as mean ± SEM. Statistical analyses were performed using SPSS 20.0 (SPSS Inc., Chicago, IL, USA). Comparisons among groups were made using a one-way ANOVA followed by Tukey’s post hoc test. Relation between serum 25(OH)D level and other indices was analyzed by Pearson’s correlation analysis. Statistical significance was set at .

3. Results

3.1. Circulating 25(OH)D, Total and HMW Adiponectin, NEFAs, and Glycerol Level

As illustrated in Table 1, plasma levels of glycerol were significantly higher in the OW and OB group compared to lean group. Meanwhile, serum NEFAs were significantly increased in the OB group compared to lean group. In contrast, compared to the lean group, HMW adiponectin was decreased in the OW and OB group; and total adiponectin was decreased in the OB group.

3.2. Relationship between 25(OH)D Level and Other Metabolic Parameters

As shown in Table 2, 25(OH)D levels were inversely associated with NEFAs and glycerol levels and positively associated with total adiponectin. There were no significant correlations between 25(OH)D level and HMW adiponectin.

3.3. Circulating Endothelial Microparticles from the Subjects

As shown in Figure 1, there is no difference for CD62E+ or CD31+/CD42b− EMPs between lean, overweight, and obese group.

(a)

(b)

(c)

(d)

Figure 1

Circulating CD62E+ and CD31+/CD42b− EMPs levels among groups. Circulating EMPs were measured in platelet poor plasma by flow cytometry with fluorochrome labeled antibodies specific for PE-CD42b, FITC-CD31, and APC-CD62E. EMPs were identified as CD62E+ and CD31+/CD42b− events with a diameter <1 μM. There is no difference for circulating CD62E+ (a) and CD31+/CD42b− EMPs (c) among the 3 groups. Representative fluorescence-activated cell sorter dot plots of CD62E+ and CD31+/CD42b− EMPs from lean, overweight, and obese group were shown in (b) and (d), respectively. Data are presented as mean ± SEM ().

4. Discussion

Serum 25(OH)D is inversely associated with BMI [10]. Previously, Husemoen et al. [11] suggested that a possible causal association existed between serum 25(OH)D and total adiponectin, and there was no association between serum 25(OH)D and HMW adiponectin. Adiponectin is synthesized as a single subunit which undergoes multimerisation to form HMW multimers prior to secretion [5]. We are perplexed by the lack of association between serum 25(OH)D and HMW adiponectin considering the close association between total and HMW adiponectin [17]. We think several reasons might explain this phenomenon. First, Schraw et al. [5] demonstrated that, for female subjects, on average half of their adiponectin is in the HMW form with the other half being hexamer and trimer, while, for male subjects, approximately equal levels of all three complexes existed in circulation. Because our subjects are solely males, HMW form could not represent the total adiponectin; accordingly a dissociation might exist for the correlations between total, HMW form adiponectin, and 25(OH)D. Second, efficient multimerisation to form the HMW multimers depends on multiple posttranslational modifications and is very sensitive to physiological stimuli such as high glucose [18]. It is likely that the posttranslational modifications of adiponectin and physiological factors such as glucose might explain the lack of the association between 25(OH)D and HMW multimers. Nevertheless, further studies by utilizing approaches that could dynamically detect the different forms of adiponectin such as mass spectrometry and gel filtration chromatography are required to further explore the associations between serum 25(OH)D and different forms of adiponectin.

Our study confirmed this finding in Chinese male subjects with varied BMI. Meanwhile, we found an inverse association existing between 25(OH)D levels and NEFA and glycerol levels. Our study is the very first to report a negative association between 25(OH)D levels and NEFAs, as well as glycerol. Vitamin D has been reported to affect adipose tissue function such as inhibiting lipolysis in human adipocytes [19]; this might be one of the mechanisms for explaining the inverse association between 25(OH)D levels and NEFAs, as well as glycerol.

Elevation of EMPs has been rapidly accepted as an alternate surrogate marker of CVDs and endothelial function [20]. CD62E+ EMPs generally reflect endothelial activation or inflammation whereas CD31+/CD42b− EMPs are released upon endothelial cell apoptosis [12]. Circulating EMPs are increased in overweight/obese individuals with metabolic syndrome [21] and in various CVDs [22]. However, in our present study we found no difference for CD62E+ EMPs or CD31+/CD42b− EMPs between lean, overweight, and obese subjects. There are several reasons for explaining this. First, it is possible that the severity of obesity (or other risk factors such as MetS or CVDs) is required to elevate circulating EMPs. Our subjects are only obese; thus there is a lack of elevation in EMPs in our present study. Second, we only measured circulating CD62E+ and CD31+/CD42b− EMPs; it is possible that other EMPs’ population such as CD146+ or CD41+ EMPs might be elevated. Last but not least, the genetic differences might also be one factor for affecting circulating EMPs. Regardless, our present study could suggest that, at least in Chinese male subjects, there is no alteration in CD62E+ and CD31+/CD42b− EMPs between lean, overweight, and obese subjects.

5. Limitations

Our study has several limitations. First, we only investigated Chinese male adults with a relatively small sample size; the extrapolation of the results to other populations will be limited. Second, we utilized Pearson’s correlation analysis to explore the correlation between plasma vitamin D, total and HMW adiponectin, and other metabolic markers. There might be confounding factors for affecting the correlation analysis.

6. Conclusions

In summary, our present results showed that (1) in Chinese male adults with varied BMI, an inverse correlation existed between 25(OH)D levels and NEFA and glycerol levels, as well as positive association between 25(OH)D and total adiponectin levels and (2) there is no significant difference for CD62E+ or CD31+/CD42b− EMPs among lean, overweight, and obese subjects.

Competing Interests

The authors declare that they have no competing interests.

Authors’ Contributions

Zhongxiao Wan, Lugang Yu, Zengli Zhang, and Ting Lei designed the experiments and wrote the paper. Zhongxiao Wan, Ting Lei, Jinbo Cheng, Baohui Xu, Xing Pang, Hui Zhou, and Lugang Yu performed the experiments and analyzed the data. All authors approved the final paper.

Acknowledgments

The authors thank the participants for their dedication and participation in the present study. This study is supported by the Natural Science Foundation of China (Grant no. 81472975) (to Zhongxiao Wan).

References

A. Tschoner, W. Sturm, J. Engl et al., “Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss,” Obesity, vol. 16, no. 11, pp. 2439–2444, 2008.
View at: Publisher Site | Google Scholar
A. Booth, A. Magnuson, J. Fouts, and M. T. Foster, “Adipose tissue: an endocrine organ playing a role in metabolic regulation,” Hormone Molecular Biology and Clinical Investigation, 2016.
View at: Publisher Site | Google Scholar
P. E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H. F. Lodish, “A novel serum protein similar to C1q, produced exclusively in adipocytes,” The Journal of Biological Chemistry, vol. 270, no. 45, pp. 26746–26749, 1995.
View at: Publisher Site | Google Scholar
M. Cnop, P. J. Havel, K. M. Utzschneider et al., “Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex,” Diabetologia, vol. 46, no. 4, pp. 459–469, 2003.
View at: Google Scholar
T. Schraw, Z. V. Wang, N. Halberg, M. Hawkins, and P. E. Scherer, “Plasma adiponectin complexes have distinct biochemical characteristics,” Endocrinology, vol. 149, no. 5, pp. 2270–2282, 2008.
View at: Publisher Site | Google Scholar
Y. Aso, R. Yamamoto, S. Wakabayashi et al., “Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin,” Diabetes, vol. 55, no. 7, pp. 1954–1960, 2006.
View at: Publisher Site | Google Scholar
Z. Wan, A. B. Thrush, M. Legare et al., “Epinephrine-mediated regulation of PDK4 mRNA in rat adipose tissue,” American Journal of Physiology—Cell Physiology, vol. 299, no. 5, pp. C1162–C1170, 2010.
View at: Publisher Site | Google Scholar
M. Ahmadian, R. E. Duncan, K. Jaworski, E. Sarkadi-Nagy, and H. S. Sul, “Triacylglycerol metabolism in adipose tissue,” Future Lipidology, vol. 2, no. 2, pp. 229–237, 2007.
View at: Publisher Site | Google Scholar
K. S. Vimaleswaran, D. J. Berry, C. Lu et al., “Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts,” PLoS Medicine, vol. 10, no. 2, Article ID e1001383, 2013.
View at: Publisher Site | Google Scholar
S. Konradsen, H. Ag, F. Lindberg, S. Hexeberg, and R. Jorde, “Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index,” European Journal of Nutrition, vol. 47, no. 2, pp. 87–91, 2008.
View at: Publisher Site | Google Scholar
L. L. N. Husemoen, T. Skaaby, T. Martinussen et al., “Investigating the causal effect of vitamin D on serum adiponectin using a mendelian randomization approach,” European Journal of Clinical Nutrition, vol. 68, no. 2, pp. 189–195, 2014.
View at: Publisher Site | Google Scholar
J. J. Jimenez, W. Jy, L. M. Mauro, C. Soderland, L. L. Horstman, and Y. S. Ahn, “Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis,” Thrombosis Research, vol. 109, no. 4, pp. 175–180, 2003.
View at: Publisher Site | Google Scholar
R. B. Arteaga, J. A. Chirinos, A. O. Soriano et al., “Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome,” The American Journal of Cardiology, vol. 98, no. 1, pp. 70–74, 2006.
View at: Publisher Site | Google Scholar
S. La Vignera, R. Condorelli, E. Vicari, R. D'Agata, and A. E. Calogero, “Circulating endothelial progenitor cells and endothelial microparticles in patients with arterial erectile dysfunction and metabolic syndrome,” Journal of Andrology, vol. 33, no. 2, pp. 202–209, 2012.
View at: Publisher Site | Google Scholar
B.-F. Zhou, “Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults,” Biomedical and Environmental Sciences, vol. 15, no. 1, pp. 83–96, 2002.
View at: Google Scholar
N. T. Jenkins, J. Padilla, L. J. Boyle, D. P. Credeur, M. Harold Laughlin, and P. J. Fadel, “Disturbed blood flow acutely induces activation and apoptosis of the human vascular endothelium,” Hypertension, vol. 61, no. 3, pp. 615–621, 2013.
View at: Publisher Site | Google Scholar
K.-W. Liang, W.-J. Lee, W.-L. Lee, C.-T. Ting, and W. H.-H. Sheu, “Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis,” Clinica Chimica Acta, vol. 405, no. 1-2, pp. 114–118, 2009.
View at: Publisher Site | Google Scholar
A. A. Richards, T. Stephens, H. K. Charlton et al., “Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational modifications,” Molecular Endocrinology, vol. 20, no. 7, pp. 1673–1687, 2006.
View at: Publisher Site | Google Scholar
H. Shi, A. W. Norman, W. H. Okamura, A. Sen, and M. B. Zemel, “1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action,” The FASEB Journal, vol. 15, no. 14, pp. 2751–2753, 2001.
View at: Google Scholar
O. Helal, C. Defoort, S. Robert et al., “Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, no. 9, pp. 665–671, 2011.
View at: Publisher Site | Google Scholar
A. Agouni, A. H. Lagrue-Lak-Hal, P. H. Ducluzeau et al., “Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome,” The American Journal of Pathology, vol. 173, no. 4, pp. 1210–1219, 2008.
View at: Publisher Site | Google Scholar
F. Dignat-George and C. M. Boulanger, “The many faces of endothelial microparticles,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 1, pp. 27–33, 2011.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2016 Zhongxiao Wan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1037

Downloads

775

Citations